drugset / Trial / NCT05691114
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease
Phase 1
Unknown
18 enrolled
Shanghai East Hospital
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, single-arm, dose escalation study, to explore the safety, tolerability and efficacy of human amniotic epithelial stem cells (hAESCs) for idiopathic Parkinson's disease (PD).
Timeline
- Start
- 2023-02
- Primary completion
- 2025-02
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hAESCs | Cell therapy | 5e+07 cells | Other |
| Subject | hAESCs | Cell therapy | 1e+08 cells | Other |
| Subject | hAESCs | Cell therapy | 1.5e+08 cells | Other |